NCT07675538

Brief Summary

Attention-Deficit/Hyperactivity Disorder (ADHD) is a lifelong neurodevelopmental disorder characterised by persistent symptoms of inattention, hyperactivity, and impulsivity. According to the DSM-5, these symptoms must be present for at least six months, have an onset in childhood, and result in significant impairment in multiple life domains. Although ADHD may be limited to childhood in some cases, most individuals continue to have symptoms and impairments in varying degrees in adult life. The prevalence of persistent ADHD among adults is estimated to be approximately 2.58%, depending on diagnostic criteria and sample selection. The increasing awareness of ADHD has led to a marked increase in referrals to mental health services, which places greater demands on the development of effective and accessible treatment options for this group. Pharmacological treatment, particularly the use of stimulants, is a common intervention for adults with ADHD and has been shown to be effective for many. However, there are also side effects associated with drug treatment, and there is a need for more evidence-based non-drug alternatives. In addition, discontinuation of medication is common in ADHD treatment. Psychological interventions include psychoeducation and cognitive behaviour therapy, as well as more specialised approaches based on Dialectical Behaviour Therapy and Goal Management Training, which aim to improve executive functions. Whilst pharmacotherapy and psychotherapeutic interventions help some people with ADHD, not all people experience favourable outcomes, which calls for alternative treatment approaches. Interventions targeting the core symptoms of ADHD, executive functions, and behaviour are particularly relevant to treatment provision. One approach to improving executive functioning that has received increasing attention is physical exercise. Studies have shown that physical activity can have a positive effect on cognitive function, executive control, and behaviour in children and adolescents with ADHD. Physical exercise may also be applied as treatment for comorbid factors common in ADHD, such as mood disorders and multiple long-term physical conditions. Despite increasing interest in physical activity as a treatment modality, research on physical exercise for adults with ADHD is still limited. The findings from studies on younger age groups point to the potential for similar effects in adults, but more research is needed to examine the effects of physical exercise as a targeted intervention in the adult population with ADHD. Among the different types of physical activity, high-intensity interval training (HIIT) has gained promise for mental health. Due to its rapid, alternating, and fast-paced style, it could prove useful for those with ADHD. However, research on high-intensity interval training interventions (HIIT) in this population is scarce. To address these unanswered questions, this project will conduct a feasibility trial for a randomised controlled trial (RCT) to assess the feasibility and acceptability of HIIT among people with ADHD.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
30

participants targeted

Target at below P25 for not_applicable

Timeline
11mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress35%
Feb 2026Jun 2027

First Submitted

Initial submission to the registry

January 15, 2026

Completed
17 days until next milestone

Study Start

First participant enrolled

February 1, 2026

Completed
5 months until next milestone

First Posted

Study publicly available on registry

June 30, 2026

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2027

Expected
29 days until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

June 30, 2026

Status Verified

June 1, 2026

Enrollment Period

1.3 years

First QC Date

January 15, 2026

Last Update Submit

June 26, 2026

Conditions

Keywords

ADHDPhysical exerciseHigh intensity training

Outcome Measures

Primary Outcomes (5)

  • Feasibility of the intervention: Recruitment rate

    Recruitment rate: Proportion of eligible participants who agree to participate in the study ((Number of participants recruited/Number of eligible participants) x 100). Aim: \>50%.

    through study completion, an average of 1 year

  • Feasibility measure: Retention rate

    Retention rate: Proportion of participants who remain in the study until completion ((Number of participants completing the study/Number of participants enrolled) x 100). Aim: \>80%.

    through study completion, an average of 1 year

  • Feasibility measure: Dropout rate

    Dropout rate: How many participants dropped out after inclusion. Registration of reasons of dropout.

    through study completion, an average of 1 year

  • Feasibility measure: Compliance

    Compliance: How many sessions each participant attended. Registration of reasons of sessions not attended.

    through study completion, an average of 1 year

  • Feasibility measure: Adherence to protocol

    Adherence to protocol: How many elements in the physical exercise program were conducted in each session. Physical exercise diary for registration of load and intensity of strength- and endurance training, respectively. Aim: \>80%. Also, registration of adherence to the total test protocol.

    through study completion, an average of 1 year

Secondary Outcomes (17)

  • In depth interview

    Participants are inviteted within two weeks after ending their participation

  • General Ability - WAIS-IV

    Within two weeks before initating intervention.

  • The Adult ADHD Self-Report Scale

    Within two weeks before initating intervention. Within two weeks after ending intervention.

  • The Working Memory Questionnaire

    Within two weeks before first intervention session and within two weeks after completion of the last session.

  • The Generalized Anxiety Disorder-7

    Within two weeks before first intervention session and within two weeks after completion of the last session.

  • +12 more secondary outcomes

Study Arms (1)

High intensity training

EXPERIMENTAL

Fourteen weeks of high intensity strenght and endurance training after a protocol.

Behavioral: High intensity training

Interventions

14 weeks of high intensity training of strenght and endurace.

High intensity training

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Above 18 years
  • An ADHD diagnosis (F90.0 in the ICD-10)

You may not qualify if:

  • Psychiatric conditions not compatible with participation incl. ongoing psychotic episode, mania, acute suicidality etc.,
  • Physical conditions precluding participation in physical testing and/or exercise
  • Comprehensive ongoing substance use determined by the Alcohol Use Disorders IdentificationTest (AUDIT; Babor et al., 2001) and the Drug Use Disorder Identification Test (DUDIT; Berman et al., 2003). An AUDIT cut-off score of 16 (high risk), and/or DUDIT score of 20 (high risk) will lead to screening with MINI International Neuropsychiatric Interview (Lecrubier etal., 1997; Sheehan et al., 1998).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Solli DPS and Kronstad DPS

Bergen, Norway

Location

MeSH Terms

Conditions

Attention Deficit Disorder with HyperactivityMotor Activity

Interventions

High-Intensity Interval Training

Condition Hierarchy (Ancestors)

Attention Deficit and Disruptive Behavior DisordersNeurodevelopmental DisordersMental DisordersBehavior

Intervention Hierarchy (Ancestors)

Physical Conditioning, HumanExerciseMotor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Study Officials

  • Kristine Sirevåg, PhD

    Solli DPS

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2026

First Posted

June 30, 2026

Study Start

February 1, 2026

Primary Completion (Estimated)

June 1, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

June 30, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

This has not been applied for to the ethical Committee.

Locations